Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capecitabine maintenance chemotherapy for advanced colorectal cancer
ChiCTR-TRC-10000789Phase 3Completed
- Sponsor
- Sun Yat-sen University Cancer Center
- Start
- Jan 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of capecitabine in colorectal cancer (CRC) (2 arms), sponsored by Sun Yat-sen University Cancer Center. Primary endpoint: Time to progression. Started Jan 2010; status: completed.
02
Drugs
capecitabine
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on ChiCTR-TRC-10000789.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-10000789.